| |
| |
|
| Insider
Information: |
Ajer Jeffrey Robert |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
100,920 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,977,498 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
100,920 |
|
|
| Total
Value |
$5,977,498 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -1.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-05-02 |
66,767 |
|
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-03-21 |
4 |
AS |
$83.90 |
$366,475 |
D/D |
(4,368) |
60,153 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-01 |
4 |
D |
$94.76 |
$86,895 |
D/D |
(917) |
60,775 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2023-08-16 |
4 |
AS |
$90.00 |
$450,000 |
D/D |
(5,000) |
60,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-10-14 |
4 |
AS |
$79.91 |
$169,489 |
D/D |
(2,121) |
61,281 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-05-13 |
4 |
D |
$82.71 |
$90,650 |
D/D |
(1,096) |
61,297 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-03-24 |
4 |
AS |
$76.30 |
$90,110 |
D/D |
(1,181) |
61,439 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
14,160 |
61,635 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,557 |
61,692 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
61,994 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-05-06 |
4 |
D |
$80.80 |
$54,863 |
D/D |
(679) |
62,393 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-03-22 |
4 |
D |
$78.52 |
$118,801 |
D/D |
(1,513) |
62,620 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,370 |
62,976 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-04-08 |
4 |
AS |
$79.98 |
$192,512 |
D/D |
(2,407) |
63,064 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,190 |
63,072 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-05-03 |
4 |
AS |
$86.03 |
$35,701 |
D/D |
(415) |
63,072 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-04-30 |
4 |
A |
$62.59 |
$21,154 |
D/D |
338 |
63,402 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-06-19 |
4 |
AS |
$124.00 |
$1,860,000 |
D/D |
(15,000) |
63,402 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-04-29 |
4 |
A |
$51.26 |
$21,275 |
D/D |
415 |
63,487 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-03-13 |
4 |
D |
$84.50 |
$645,918 |
D/D |
(7,644) |
63,886 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-03-18 |
4 |
AS |
$77.99 |
$102,011 |
D/D |
(1,308) |
64,133 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,840 |
64,521 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
9,370 |
65,223 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-22 |
4 |
AS |
$81.00 |
$167,913 |
D/D |
(2,073) |
65,385 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-03-16 |
4 |
D |
$77.21 |
$99,369 |
D/D |
(1,287) |
65,441 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-04-01 |
4 |
AS |
$82.00 |
$126,034 |
D/D |
(1,537) |
65,471 |
0 |
- |
|
174 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
